Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Angiotensin-converting enzyme cleavage of the Alzheimer's beta-amyloid peptide

Includes bibliographical references

Saved in:
Bibliographic Details
Main Author: Larmuth, Kate Morgan
Other Authors: Sturrock, Edward D
Format: Thesis
Language:English
Published: Division of Medical Biochemistry 2016
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613237356265472
access_status_str Open Access
author Larmuth, Kate Morgan
author2 Sturrock, Edward D
author_browse Larmuth, Kate Morgan
Sturrock, Edward D
author_facet Sturrock, Edward D
Larmuth, Kate Morgan
author_sort Larmuth, Kate Morgan
collection Thesis
description Includes bibliographical references
format Thesis
id oai:open.uct.ac.za:11427/16561
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:32:57.328Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2016
publishDateRange 2016
publishDateSort 2016
publisher Division of Medical Biochemistry
publisherStr Division of Medical Biochemistry
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/16561 Angiotensin-converting enzyme cleavage of the Alzheimer's beta-amyloid peptide Larmuth, Kate Morgan Sturrock, Edward D Medical Biochemistry Includes bibliographical references Angiotensin-1 converting enzyme (ACE) is a zinc metallopeptidase that consists of two homologous catalytic domains (N and C) with different substrate specificities. ACE is a central component of the intrinsic brain renin angiotensin-aldosterone system (BRAAS), well renowned as the regulator of blood pressure. The BRAAS has alternate functions that extend beyond fluid and blood pressure homeostasis into areas such as neurological function. As a result, it is implicated in many neurodegenerative diseases including Alzheimer's disease (AD). ACE's specific mechanistic role in AD is not entirely clear and is somewhat controversial. However, it has been shown that ACE hydrolyses the amyloid beta (Aβ) peptide, the putative causative agent of AD. This study aimed to investigate the molecular basis of ACE hydrolysis of Aβ by determining : 1) the kinetic parameters of five different forms of human ACE with various N-terminal amyloid beta (Aβ) substrates; 2) the specific active site determinants of Aβ-domain selectivity; and 3) the high-resolution crystal structures of the N-domain of ACE in complex with Aβ(1-16), Aβ(10-16), Aβ(4-10), the FRET Aβ(4-10)Y and Aβ(35-42) peptides. For the physiological Aβ(1-16) peptide, a novel ACE cleavage site was found at His14/Gln15. Furthermore, Aβ(1-16 ) was preferentially cleaved by the truncated N-domain; however, the presence of an inactive C-domain in full-length ACE greatly reduced enzyme activity and affected domain-selectivity. Two fluorogenic substrates, designed specifically to assess ACE's mechanism of Aβ hydrolysis Aβ(4-10)Q and Aβ(4-10)Y, underwent endoproteolytic cleavage at the Asp7/Ser8 bond. The Aβ(4-10)Q peptide was a poor substrate of ACE but was N-selective, with a selectivity driven largely by interactions with the domain-specific residues of the S2 and S2' pockets. The selectivity of the S2' residues were confirmed with a similar, more physiological, fluorogenic Aβ(4-10)Y peptide. This work provides further understanding towards the substrate determinants of N-selectivity, highlighting the importance of the S2' Ser357. ACE C-domain hydrolysed Aβ(4-10)Y with modest efficiency compared to the other substrates, where hydrolysis under the same conditions did not occur. Moreover, Aβ(4-10)Y also displayed N-domain selectivity. In contrast to Aβ(1-16) and Aβ(410)Q, both sACE and the double C-domain (CC-sACE) construct showed positive domain cooperativity towards Aβ(4-10)Y. The high-resolution crystal structures of the N-domain in complex with five Aβ peptide fragments provided an overlapping, conserved, molecular mechanism of peptide binding and evidence of the enzyme's broad exoprotease activity. In addition to the kinetic and structural studies, ACE's signalling response to the N-selective Aβ(1-16) and Aβ(1-42) was investigated using immunodetection and mass spectrometry. Similar to the ACE inhibitor lisinopril, the Aβ peptides elicited ACE signalling by phosphorylation of the cytoplasmic Ser1270 residue and JNK activation. The signalling response of ACE was coupled to increased ACE activity an d expression on treatment with Aβ(1-42). These studies allowed us to rationalise the increased ACE activity and expression found in AD, may arise through direct interactions with Aβ. This work provides a kinetic, structural and mechanistic understanding of the selective cleavage of Aβ by the N and C catalytic sites of ACE. Due to the broad substrate specificity of the two domains of ACE, and the overarching N- selectivity of Aβ hydrolysis, these findings provide rationale for further in vivo pharmacological studies on the mechanism of action C- domain-selective inhibitors, in the context of AD. 2016-01-26T12:03:31Z 2016-01-26T12:03:31Z 2015 Doctoral Thesis Doctoral PhD http://hdl.handle.net/11427/16561 eng application/pdf Division of Medical Biochemistry Faculty of Health Sciences University of Cape Town
spellingShingle Medical Biochemistry
Larmuth, Kate Morgan
Angiotensin-converting enzyme cleavage of the Alzheimer's beta-amyloid peptide
thesis_degree_str Doctoral
title Angiotensin-converting enzyme cleavage of the Alzheimer's beta-amyloid peptide
title_full Angiotensin-converting enzyme cleavage of the Alzheimer's beta-amyloid peptide
title_fullStr Angiotensin-converting enzyme cleavage of the Alzheimer's beta-amyloid peptide
title_full_unstemmed Angiotensin-converting enzyme cleavage of the Alzheimer's beta-amyloid peptide
title_short Angiotensin-converting enzyme cleavage of the Alzheimer's beta-amyloid peptide
title_sort angiotensin converting enzyme cleavage of the alzheimer s beta amyloid peptide
topic Medical Biochemistry
url http://hdl.handle.net/11427/16561
work_keys_str_mv AT larmuthkatemorgan angiotensinconvertingenzymecleavageofthealzheimersbetaamyloidpeptide